Robert F. Kennedy Jr., nominated to lead HHS under President Donald Trump’s second term, brings a range of healthcare positions that could directly and indirectly influence public health, pharmaceuticals and health systems.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
